Gottlieb Joins HHS Transition Team; Will Next Stop Be FDA?
Former US FDA, CMS official has been among those thought to be in the running for Trump's FDA commissioner nomination.
You may also be interested in...
Incoming Office of Generic Drugs Director Sally Choe is largely unfamiliar to industry, but potentially offers a new perspective.
In the wake of 21st Century Cures legislation, next commissioner will have strong support across party lines to undertake smarter regulation aimed at improving the efficiency of the drug development process, former FDA head McClellan says.
Incoming president will not hold over any FDA political appointees from the Obama administration, but what exactly his stamp on the agency will be remains unclear.